Veoneer Stock Forecast, Price & News

Veoneer (NYSE:VNE) Frequently Asked Questions

Is Veoneer a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 3 sell ratings and 7 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Veoneer stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VNE, but not buy additional shares or sell existing shares.
View analyst ratings for Veoneer or view top-rated stocks.

How has Veoneer's stock price been impacted by Coronavirus (COVID-19)?

Veoneer's stock was trading at $8.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VNE stock has increased by 294.0% and is now trading at $35.42.
View which stocks have been most impacted by COVID-19.

When is Veoneer's next earnings date?

Veoneer is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Veoneer.

How were Veoneer's earnings last quarter?

Veoneer, Inc. (NYSE:VNE) issued its quarterly earnings results on Tuesday, October, 26th. The company reported ($0.84) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.89) by $0.05. The business had revenue of $391 million for the quarter, compared to analyst estimates of $411.83 million. Veoneer had a negative net margin of 23.39% and a negative trailing twelve-month return on equity of 35.98%. The firm's revenue was up 5.4% on a year-over-year basis. During the same period in the prior year, the business posted ($0.96) earnings per share.
View Veoneer's earnings history.

What price target have analysts set for VNE?

10 analysts have issued twelve-month price objectives for Veoneer's stock. Their forecasts range from $18.00 to $37.00. On average, they anticipate Veoneer's stock price to reach $30.27 in the next year. This suggests that the stock has a possible downside of 14.5%.
View analysts' price targets for Veoneer or view top-rated stocks among Wall Street analysts.

Who are Veoneer's key executives?

Veoneer's management team includes the following people:

• Jan Carlson, Chairman, President & Chief Executive Officer
• Steven Rodé, Executive Vice President-Operations
• Ray Pekar, Chief Financial Officer
• Steven Jenkins, Chief Technology Officer & Executive VP
• Ola Bostrom, Vice President-Research & Patents

Who are some of Veoneer's key competitors?

Some companies that are related to Veoneer include Icahn Enterprises (IEP), Lear (LEA), BorgWarner (BWA), Isuzu Motors (ISUZY), Autoliv (ALV), Gentex (GNTX), Valeo (VLEEY), Luminar Technologies (LAZR), Adient (ADNT), LCI Industries (LCII), Allison Transmission (ALSN), Dorman Products (DORM), Dana (DAN), Visteon (VC) and Gentherm (THRM).
View all of VNE's competitors.

What other stocks do shareholders of Veoneer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Pfizer (PFE), Canadian Natural Resources (CNQ), GlaxoSmithKline (GSK), Carnival Co. & (CCL), Dominion Energy (D), Delta Air Lines (DAL), Enterprise Products Partners (EPD), Energy Transfer (ET), Gilead Sciences (GILD) and Groupon (GRPN).

What is Veoneer's stock symbol?

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Who are Veoneer's major shareholders?

Veoneer's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.75%), Segantii Capital Management Ltd (0.97%), Geode Capital Management LLC (0.77%), Balyasny Asset Management LLC (0.74%), Balyasny Asset Management LLC (0.74%) and Dimensional Fund Advisors LP (0.68%).
View institutional ownership trends for Veoneer.

Which major investors are selling Veoneer stock?

VNE stock was sold by a variety of institutional investors in the last quarter, including Credit Suisse AG, Morgan Stanley, Goldman Sachs Group Inc., PEAK6 Investments LLC, Mitsubishi UFJ Kokusai Asset Management Co. Ltd., BlackRock Inc., State of New Jersey Common Pension Fund D, and Tudor Investment Corp Et Al.
View insider buying and selling activity for Veoneer or view top insider-selling stocks.

Which major investors are buying Veoneer stock?

VNE stock was purchased by a variety of institutional investors in the last quarter, including Segantii Capital Management Ltd, Balyasny Asset Management LLC, Balyasny Asset Management LLC, Versor Investments LP, Magnetar Financial LLC, IndexIQ Advisors LLC, Water Island Capital LLC, and TIG Advisors LLC.
View insider buying and selling activity for Veoneer or or view top insider-buying stocks.

How do I buy shares of Veoneer?

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Veoneer's stock price today?

One share of VNE stock can currently be purchased for approximately $35.42.

How much money does Veoneer make?

Veoneer has a market capitalization of $3.97 billion and generates $1.37 billion in revenue each year. The company earns $-545 million in net income (profit) each year or ($3.48) on an earnings per share basis.

How many employees does Veoneer have?

Veoneer employs 7,543 workers across the globe.

What is Veoneer's official website?

The official website for Veoneer is www.veoneer.com.

Where are Veoneer's headquarters?

Veoneer is headquartered at KLARABERGSVIADUKTEN 70 SECTION C6 BOX 13089, STOCKHOLM V7, 10302.

How can I contact Veoneer?

Veoneer's mailing address is KLARABERGSVIADUKTEN 70 SECTION C6 BOX 13089, STOCKHOLM V7, 10302. The company can be reached via phone at (685) 277-6200 or via email at [email protected].